NO961460D0 - Antitrombotiske azacykloalkylalkanoylpeptider og -pseudopeptider - Google Patents

Antitrombotiske azacykloalkylalkanoylpeptider og -pseudopeptider

Info

Publication number
NO961460D0
NO961460D0 NO961460A NO961460A NO961460D0 NO 961460 D0 NO961460 D0 NO 961460D0 NO 961460 A NO961460 A NO 961460A NO 961460 A NO961460 A NO 961460A NO 961460 D0 NO961460 D0 NO 961460D0
Authority
NO
Norway
Prior art keywords
pct
date
pseudopeptides
sec
prevention
Prior art date
Application number
NO961460A
Other languages
English (en)
Other versions
NO961460L (no
Inventor
Scott I Klein
Bruce F Molino
Original Assignee
Rhone Poulenc Rorer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Inc filed Critical Rhone Poulenc Rorer Inc
Publication of NO961460D0 publication Critical patent/NO961460D0/no
Publication of NO961460L publication Critical patent/NO961460L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO961460A 1993-10-15 1996-04-12 Antitrombotiske azacykloalkylalkanoylpeptider og -pseudopeptider NO961460L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13882093A 1993-10-15 1993-10-15
PCT/US1994/012135 WO1995010295A1 (en) 1993-10-15 1994-10-17 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides

Publications (2)

Publication Number Publication Date
NO961460D0 true NO961460D0 (no) 1996-04-12
NO961460L NO961460L (no) 1996-06-17

Family

ID=22483811

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961460A NO961460L (no) 1993-10-15 1996-04-12 Antitrombotiske azacykloalkylalkanoylpeptider og -pseudopeptider

Country Status (27)

Country Link
US (1) US5866685A (no)
EP (1) EP0812205B1 (no)
JP (1) JP3032297B2 (no)
KR (1) KR100304332B1 (no)
CN (1) CN1135717A (no)
AT (1) ATE199727T1 (no)
AU (1) AU703854B2 (no)
BG (1) BG63166B1 (no)
BR (1) BR9407839A (no)
CA (1) CA2174097C (no)
CZ (1) CZ291378B6 (no)
DE (1) DE69426897T2 (no)
DK (1) DK0812205T3 (no)
ES (1) ES2155122T3 (no)
FI (1) FI961634A7 (no)
GR (1) GR3035581T3 (no)
HU (1) HU222248B1 (no)
NO (1) NO961460L (no)
NZ (1) NZ275948A (no)
PL (1) PL181749B1 (no)
PT (1) PT812205E (no)
RO (1) RO115520B1 (no)
RU (1) RU2134695C1 (no)
SG (1) SG64919A1 (no)
SK (1) SK47796A3 (no)
UA (1) UA44258C2 (no)
WO (1) WO1995010295A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780590A (en) * 1993-10-15 1998-07-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
US6274705B1 (en) 1996-05-02 2001-08-14 Aventis Pharmaceuticals Products Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
UA44258C2 (uk) * 1993-10-15 2002-02-15 Рон-Пуленк Рорер Фармасьютікалз Інк. Антитромботичні азациклоалкілалканоілпептиди та псевдопептиди, фармацевтична композиція, що їх містить, спосіб профілактики або лікування тромбозу у ссавців (варіанти)
PL331772A1 (en) 1996-08-21 1999-08-02 Rhone Poulenc Rorer Pharma Stable non-hygroscopic crystalline form of n-[n-n-(4-piperidin-4-yl)-n-ethylglycin] compounds
AU754936B2 (en) * 1996-11-27 2002-11-28 Aventis Pharmaceuticals Inc. Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound
WO1999019294A1 (en) * 1997-05-14 1999-04-22 Aventis Pharmaceuticals Products Inc. Legal/Patents Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
EA002724B1 (ru) * 1997-10-10 2002-08-29 Авентис Фармасьютикалз Продактс Инк. Способ получения азациклоалкилалканоилпсевдотетрапептидов
WO2000040601A1 (en) * 1998-12-30 2000-07-13 Aventis Pharmaceuticals Products Inc. Process for preparing a stable non-hygroscopic crystalline n-[n-[n- piperdin- 4-yl)butanoyl)- n.ethylglycyl]- (l)-aspartyl] -ss-cyclohexylalanine amide
RU2250212C2 (ru) * 2000-01-28 2005-04-20 Авентис Фарма Дойчланд Гмбх Способ получения ацетиламидиниофенилаланилциклогексилглицилпиридиниоаланинамидов
PL205134B1 (pl) * 2000-03-27 2010-03-31 Scripps Research Inst Pochodne glicylolizyny, preparat farmaceutyczny i zastosowanie pochodnych glicylolizyny
CN101735307B (zh) * 2008-11-18 2012-05-30 北京航空航天大学 一种血小板膜糖蛋白寡肽或其修饰物/衍生物以及它们的应用
CA2876177C (en) * 2012-06-11 2022-06-14 The Cleveland Clinic Foundation Treatment and prevention of cardiovascular disease and thrombosis

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors
FR2608160B1 (fr) * 1986-12-15 1989-03-31 Inst Nat Sante Rech Med Nouveaux derives peptidiques et leur application notamment en therapeutique
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US4992463A (en) * 1988-07-20 1991-02-12 Monsanto Company Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US5037808A (en) * 1988-07-20 1991-08-06 Monsanto Co. Indolyl platelet-aggregation inhibitors
CA2008116C (en) * 1989-02-23 2001-11-20 Thomas Weller Glycine derivatives
US5023233A (en) * 1989-07-28 1991-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
CA2066047A1 (en) * 1989-09-29 1991-03-30 Scott I. Klein Anti-thrombotic peptides and pseudopeptides
US5051405A (en) * 1989-10-10 1991-09-24 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-thrombotic peptides and pseudopeptides
US5064814A (en) 1990-04-05 1991-11-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-thrombotic peptide and pseudopeptide derivatives
IL99539A0 (en) * 1990-09-27 1992-08-18 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
NZ239876A (en) * 1990-09-27 1993-12-23 Merck & Co Inc Glycyl-b-alanine derivatives and pharmaceutical compositions thereof.
EP0503203A1 (en) * 1991-03-15 1992-09-16 Merrell Dow Pharmaceuticals Inc. Novel thrombin inhibitors
JPH08503920A (ja) * 1991-04-11 1996-04-30 ローヌ−プーラン ローラー インターナショナル（ホウルディングス） インコーポレイテッド 抗血栓ペプチドおよび偽ペプチド誘導体
SE9102462D0 (sv) * 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
UA44258C2 (uk) * 1993-10-15 2002-02-15 Рон-Пуленк Рорер Фармасьютікалз Інк. Антитромботичні азациклоалкілалканоілпептиди та псевдопептиди, фармацевтична композиція, що їх містить, спосіб профілактики або лікування тромбозу у ссавців (варіанти)

Also Published As

Publication number Publication date
CZ108496A3 (en) 1996-12-11
CA2174097A1 (en) 1995-04-20
GR3035581T3 (en) 2001-06-29
HU9600983D0 (en) 1996-06-28
PL313975A1 (en) 1996-08-05
JP3032297B2 (ja) 2000-04-10
NZ275948A (en) 1997-02-24
ES2155122T3 (es) 2001-05-01
RO115520B1 (ro) 2000-03-30
JPH09507213A (ja) 1997-07-22
EP0812205A4 (en) 1999-03-31
AU8123794A (en) 1995-05-04
US5866685A (en) 1999-02-02
EP0812205A1 (en) 1997-12-17
HUT73856A (en) 1996-09-30
PT812205E (pt) 2001-08-30
BG63166B1 (bg) 2001-05-31
UA44258C2 (uk) 2002-02-15
AU703854B2 (en) 1999-04-01
PL181749B1 (pl) 2001-09-28
CZ291378B6 (cs) 2003-02-12
FI961634L (fi) 1996-05-23
FI961634A7 (fi) 1996-05-23
DK0812205T3 (da) 2001-04-17
BR9407839A (pt) 1997-05-13
BG100544A (bg) 1996-11-29
ATE199727T1 (de) 2001-03-15
DE69426897D1 (de) 2001-04-19
DE69426897T2 (de) 2001-07-05
HU222248B1 (hu) 2003-05-28
RU2134695C1 (ru) 1999-08-20
NO961460L (no) 1996-06-17
SG64919A1 (en) 1999-05-25
WO1995010295A1 (en) 1995-04-20
CN1135717A (zh) 1996-11-13
EP0812205B1 (en) 2001-03-14
KR100304332B1 (ko) 2001-11-26
HK1006225A1 (en) 1999-02-19
CA2174097C (en) 2002-06-04
SK47796A3 (en) 1997-03-05
FI961634A0 (fi) 1996-04-12

Similar Documents

Publication Publication Date Title
RU93054168A (ru) Димер молекулярного варианта аро-липопротеина, способ его получения, фармацевтическая композиция на его основе
DK0812205T3 (da) Antithrombotiske azacycloalkylalkanoylpeptider og -pseudopeptider
WO2001078709A3 (en) Treatment of neurodegenerative disease
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
EA199900778A1 (ru) ГЕТЕРОЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ И ИХ ИСПОЛЬЗОВАНИЕ ДЛЯ ИНГИБИРОВАНИЯ β-АМИЛОИДНОГО ПЕПТИДА
BG103521A (en) Substituted pyrimidinon and pyridon compounds and methods for their application
EA199900490A1 (ru) СПОСОБЫ И СОЕДИНЕНИЯ ДЛЯ ИНГИБИРОВАНИЯ ВЫДЕЛЕНИЯ β-АМИЛОИДНОГО ПЕПТИДА И/ИЛИ ЕГО СИНТЕЗА
IL112111A (en) Peptides having growth hormone releasing properties and pharmaceutical compositions containing them
EA200000608A1 (ru) Предотвращение и лечение амилоидогенного заболевания
DE68919361D1 (de) Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
KR960702318A (ko) 근육 질병 및 장애의 치료방법
FI952593A0 (fi) Hyytymistä estävä aine
BG103512A (en) Substituted pyramidine compounds and their application
CA2179857A1 (en) Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury
KR960000248A (ko) 골대사 질환 치료제
CA2065889A1 (en) Increasing the choroidal blood flow
NO961357D0 (no) Nye terapeutisk aktive peptidforbindelser i blodkoagulasjonskaskaden, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
MX9207343A (es) Derivados antitromboticos de acido diaminoalcanoico.
CA2060333A1 (en) Use of pyrimido-benzothiazine derivatives
RU95104302A (ru) Аппликационный материал лечебно-профилактического назначения
ES2080657A1 (es) Proteasas modificadas.
RU96106827A (ru) Способ профилактики образования кист поджелудочной железы

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application